|
|
||||||||
Eur J Cardiothorac Surg 2000;17:426-430
© 2000 Elsevier Science NL
Klinik für Herz- und Gefäßchirurgie, Deutsches Herzzentrum, Klinik an der Technischen, Universität München, Lazarettstraße 36, 80636 Munich, Germany
Corresponding author. Tel.: +49-89-1218-4111; fax: +49-89-1218-4113
e-mail: chinfo{at}dhm.mhn.de
Objective: In patients with congenital mitral-valve disease, reconstructive surgery is the primary goal. However, in cases with severely dysplastic valves or failed repair, mitral-valve replacement (MVR) is the only option. We analyzed, retrospectively, data of 35 patients younger than 6 years of age, who underwent MVR at our institution.Methods: Between 1974 and 1997, 35 children underwent MVR. The ages ranged from 2.7 months to 5.5 years (mean=1.9±1.7 years) and body weight varied between 3.2 and 16.7 kg (mean=8.2±4 kg). The main indication (57%) for valve replacement was severe mitral-valve insufficiency. Eighteen patients (51%) had undergone at least one previous reconstructive operation (mean=1.46±1.86 years) before the MVR. In 29 cases (83%), mechanical prostheses were implanted. Six patients received a bioprosthesis. The size of the prostheses ranged between 14 and 27 mm.Results: The overall hospital mortality was 17.1% (6/35), and decreased from 33 (19741985) to 11.5% (19861997). Seven children died late. The actuarial survival after 20 years was 51.2±13.3%. Eight patients (23%) required 10 reoperations (8.2%/100 patient-years). Freedom from reoperation at 10 years was 50±22%. Valve-related complications were thrombo-embolism (n=2; 1.6%/100 patient-years), hemorrhage (n=1; 0.8%/100 patient-years), structural deterioration (n=3; 2.5%/100 patient-years) and non-structural dysfunction (n=3; 2.5%/100 patient-years). Follow-up is 96% complete, with a total of 122 patient-years (mean=4.2±4.7 years). Eighty six percent of the patients are in New York Heart Association (NYHA) class I, 95% have sinus rhythm and 59% do not need medication. All survivors, except for those who received a bioprosthesis, were placed on a regimen of Phenprocoumon (Marcumar®), aiming to maintain the International Normalized Ratio (INR) between 2.5 and 3.5. In one third of these children, self-management of oral anticoagulation was performed either by the patients or their parents.Conclusions: MVR in small children still carries a high risk. In our experience, the long-term results are satisfying. After failed reconstructive surgery, or as a primary procedure, we prefer mechanical prostheses. They are well tolerated and the incidence of anticoagulation-related complications is low.
Key Words: Mitral-valve replacement Children Mechanical prostheses
This article has been cited by other articles:
![]() |
G. Oppido, B. Davies, D. M. McMullan, A. D. Cochrane, M. M.H. Cheung, Y. d'Udekem, and C. P. Brizard Surgical treatment of congenital mitral valve disease: Midterm results of a repair-oriented policy. J. Thorac. Cardiovasc. Surg., June 1, 2008; 135(6): 1313 - 1321.e4. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Monagle, E. Chalmers, A. Chan, G. deVeber, F. Kirkham, P. Massicotte, and A. D. Michelson Antithrombotic Therapy in Neonates and Children: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition) Chest, June 1, 2008; 133(6_suppl): 887S - 968S. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Ackermann, G. Balling, A. Eicken, T. Gunther, C. Schreiber, and J. Hess Replacement of the systemic atrioventricular valve with a mechanical prosthesis in children aged less than 6 years: Late clinical results of survival and subsequent replacement J. Thorac. Cardiovasc. Surg., September 1, 2007; 134(3): 750 - 756. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. P. Sosland, J. L. Vacek, and M. E. Gorton Congenital mitral stenosis: A rare presentation and novel approach to management J. Thorac. Cardiovasc. Surg., February 1, 2007; 133(2): 572 - 573. [Full Text] [PDF] |
||||
![]() |
H. A. Vohra, S. Laker, O. Stumper, J. V. De Giovanni, J. G. Wright, D. J. Barron, and W. J. Brawn Predicting the performance of mitral prostheses implanted in children under 5 years of age. Eur. J. Cardiothorac. Surg., May 1, 2006; 29(5): 688 - 692. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. B. McElhinney, M. C. Sherwood, J. F. Keane, P. J. del Nido, C. S.D. Almond, and J. E. Lock Current Management of Severe Congenital Mitral Stenosis: Outcomes of Transcatheter and Surgical Therapy in 108 Infants and Children Circulation, August 2, 2005; 112(5): 707 - 714. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. Kanter, J. M. Forbess, and P. M. Kirshbom Redo Mitral Valve Replacement in Children Ann. Thorac. Surg., August 1, 2005; 80(2): 642 - 646. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. D. J. Ten Harkel, A. H. Cromme-Dijkhuis, B. C.C. Heinerman, W. C. Hop, and A. J.J.C. Bogers Development of Left Atrioventricular Valve Regurgitation After Correction of Atrioventricular Septal Defect Ann. Thorac. Surg., February 1, 2005; 79(2): 607 - 612. [Abstract] [Full Text] [PDF] |
||||
![]() |
F. Kojori, R. Chen, C. A. Caldarone, S. L. Merklinger, A. Azakie, W. G. Williams, G. S. Van Arsdell, J. Coles, and B. W. McCrindle Outcomes of mitral valve replacement in children: A competing-risks analysis J. Thorac. Cardiovasc. Surg., November 1, 2004; 128(5): 703 - 709. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Raghuveer, C. A. Caldarone, C. B. Hills, D. L. Atkins, J. M. Belmont, and J. H. Moller Predictors of Prosthesis Survival, Growth, and Functional Status Following Mechanical Mitral Valve Replacement in Children Aged <5 Years, a Multi-Institutional Study Circulation, September 9, 2003; 108(90101): II-174 - 179. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. T. Mahle, J. W. Gaynor, and T. L. Spray Atrioventricular valve replacement in patients with a single ventricle Ann. Thorac. Surg., July 1, 2001; 72(1): 182 - 186. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Alexiou, M. Galogavrou, Q. Chen, A. McDonald, A. P. Salmon, B. K. Keeton, M. P. Haw, and J. L. Monro Mitral valve replacement with mechanical prostheses in children: improved operative risk and survival Eur. J. Cardiothorac. Surg., July 1, 2001; 20(1): 105 - 113. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| ANN THORAC SURG | ASIAN CARDIOVASC THORAC ANN | EUR J CARDIOTHORAC SURG |
| J THORAC CARDIOVASC SURG | ICVTS | ALL CTSNet JOURNALS |